Onyvax Company

Onyvax develops cancer therapies that harness the selective power of the immune system to seek out and destroy tumor cells.

Headquarters: Bradford, Somerset, United Kingdom
Last Funding Type: Series C
Investors Number: 5
Last Funding Date: 2006-05-08
Employee Number: 11-50
Total Funding: 29810445
Founded Date: 1997-01-01
Industry: Whole-Cell Antigens
Funding Status: Late Stage Venture